Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin dosing by Rule of Threes versus Williams guideline in elective cesarean delivery
IRCT20120430009593N13Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of oxytocin in uterine atony (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Mean oxytocin dose. Started Sep 2016; status: completed.
02
Drugs
oxytocin
03
Conditions
uterine atony
Beyond the preview
Go deeper on IRCT20120430009593N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120430009593N13.